Advertisement
Screener

ImmuCell Corporation (ICCC) Obligations, Fair Value Disclosure

2.8 / 5 stars · 68/120 Roast Me

ImmuCell Corporation Obligations, Fair Value Disclosure

ImmuCell Corporation (ICCC) had Obligations, Fair Value Disclosure of $9.14 million as of 2021-12-31, per its 10-K filed 2022-03-30.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)

us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations · last filed 2022-03-30

  • 2021-12-31: Obligations, Fair Value Disclosure $9.14M.
  • 2021-09-30: Obligations, Fair Value Disclosure $9.33M.
  • 2021-06-30: Obligations, Fair Value Disclosure $9.12M.
  • 2021-03-31: Obligations, Fair Value Disclosure $9.31M.
Period endObligations, Fair Value Disclosure
2021-12-31$9.14M
10-K · filed 2022-03-30
2021-09-30$9.33M
10-Q · filed 2021-11-15
2021-06-30$9.12M
10-Q · filed 2021-08-12
2021-03-31$9.31M
10-Q · filed 2021-05-13
2020-12-31$9.50M
10-K · filed 2022-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92